These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8465795)

  • 21. [Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
    Arcensio SR; Barretto AC; Szambock F; Mady C; Arteaga E; da Luz PL; Bellotti G; Pileggi F
    Arq Bras Cardiol; 1994 Nov; 63(5):409-13. PubMed ID: 7611921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
    Melloni R; Scarazatti E; Gandini C; Melloni GF
    Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1121-8. PubMed ID: 3331290
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic response to ibopamine in acute myocardial infarction.
    Taniguchi H; Iwasaka T; Sugiura T; Takayama Y; Sumimoto T; Onoyama H; Takashima H; Nakamura S; Inada M
    Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
    Girbes AR; Kalisvaart CJ; Van Veldhuisen DJ; Tan ET; Smit AJ; Reitsma WD; Pasteuning WH
    Eur Heart J; 1993 Feb; 14(2):279-83. PubMed ID: 8095455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.
    Cocchieri M; Alunni GF; Del Favero A; Fortunati F; Bardelli G; Capponi EA; Regi L; Boschetti E
    Cardiology; 1990; 77 Suppl 5():36-42. PubMed ID: 2126222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
    Sher D; Licciardello L; Ferrari V; Sirtori F; Cesana B
    Arzneimittelforschung; 1991 Apr; 41(4):402-9. PubMed ID: 1859514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and coronary hemodynamic actions of the novel inotropic agent, ibopamine, and the de-esterified metabolite and active form, epinine: relationship to left ventricular performance in the dog.
    Kopia GA; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1988 Aug; 246(2):434-40. PubMed ID: 3404441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
    Van Veldhuisen DJ; Crijns HJ; Girbes AR; Tobé TJ; Wiesfeld AC; Lie KI
    Am J Cardiol; 1991 Nov; 68(11):1194-202. PubMed ID: 1683146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 32. Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
    Rousseau MF; Konstam MA; Benedict CR; Donckier J; Galanti L; Melin J; Kinan D; Ahn S; Ketelslegers JM; Pouleur H
    Am J Cardiol; 1994 Mar; 73(7):488-93. PubMed ID: 7908164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
    Caponnetto S; Allegro A; Bellotti G; Cataldi A; Salvemini M; Portioli I; Prati PL; Gambelli G; Boccanelli A; Zacharo E
    Arzneimittelforschung; 1986 Feb; 36(2A):386-90. PubMed ID: 3518725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure.
    Francis GS; Goldsmith SR; Ziesche SM; Cohn JN
    Am J Cardiol; 1982 Apr; 49(5):1152-6. PubMed ID: 7064841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study.
    Kleber FX; Thyroff-Friesinger U
    Cardiology; 1990; 77 Suppl 5():67-74. PubMed ID: 2279255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Hamada M; Konishi T; Nakano T
    Kokyu To Junkan; 1989 Jul; 37(7):773-8. PubMed ID: 2799097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
    Missale C; Metra M; Sigala S; Memo M; Dei Cas L; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S72-6. PubMed ID: 2483443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.
    Kleber FX; Thyroff-Friesinger U
    Cardiology; 1990; 77 Suppl 5():75-80. PubMed ID: 2279256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.